In various cancers, TYK2 overexpression or GOF mutations lead to STAT1 or STAT3 activation and upregulation of anti-apoptotic proteins, including B-cell CLL/lymphoma-2 (BCL-2) and myeloid cell leukaemia-1 (MCL-1) [20,41]. The gene discussed is MCL1; the disease is cancer.